DOCCONSULT ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
Loading...

Loading...

Loading...

Loading...

Loading...

Loading...

Loading...

Bankruptcy Risk 
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
2024
2024/9
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  11.5% 10.6% 24.4% 12.7% 13.0%  
Credit score (0-100)  21 22 2 17 18  
Credit rating  BB BB B BB BB  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
2024
2024/9

Net sales  0 0 0 0 0  
Gross profit  2.0 1.8 -3.4 3.1 2.1  
EBITDA  2.0 1.8 -3.4 3.1 2.1  
EBIT  2.0 1.8 -3.4 3.1 2.1  
Pre-tax profit (PTP)  2.0 1.8 17.0 3.1 2.2  
Net earnings  0.9 1.4 12.0 2.4 1.7  
Pre-tax profit without non-rec. items  2.0 1.8 17.0 3.1 2.2  

 
See the entire income statement

Balance sheet (kDKK) 
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
2024
2024/9

Tangible assets total  0.0 0.0 0.0 0.0 0.0  
Shareholders equity total  62.3 64.3 76.3 53.7 55.5  
Interest-bearing liabilities  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  70.4 72.1 96.4 64.0 61.2  

Net Debt  -8.2 -11.3 -96.4 -59.8 -32.5  
 
See the entire balance sheet

Volume 
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
2024
2024/9

Net sales  0 0 0 0 0  
Net sales growth  -100.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  2.0 1.8 -3.4 3.1 2.1  
Gross profit growth  -55.9% -9.3% 0.0% 0.0% -31.4%  
Employees  0 0 0 0 0  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  70 72 96 64 61  
Balance sheet change%  2.4% 2.4% 33.6% -33.6% -4.3%  
Added value  2.0 1.8 -3.4 3.1 2.1  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 0 0 0 0  

Net sales trend  -2.0 0.0 0.0 0.0 0.0  
EBIT trend  3.0 4.0 -1.0 1.0 2.0  

Profitability 
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
2024
2024/9
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  100.0% 100.0% 100.0% 100.0% 100.0%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  2.8% 2.5% 21.0% 3.9% 3.5%  
ROI %  3.2% 2.8% 25.1% 4.8% 4.0%  
ROE %  1.5% 2.2% 17.1% 3.7% 3.1%  

Solidity 
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
2024
2024/9
Equity ratio %  88.5% 89.2% 79.2% 84.0% 90.6%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -418.7% -634.6% 2,830.8% -1,922.8% -1,524.8%  
Gearing %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 0.0% 0.0% 0.0%  

Liquidity 
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
2024
2024/9
Quick Ratio  8.7 9.2 4.8 6.2 10.6  
Current Ratio  8.7 9.2 4.8 6.2 10.6  
Cash and cash equivalent  8.2 11.3 96.4 59.8 32.5  

Capital use efficiency 
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
2024
2024/9
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  62.3 64.3 76.3 53.7 55.5  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
2024
2024/9
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 0 0 0  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 0 0 0  
EBIT / employee  0 0 0 0 0  
Net earnings / employee  0 0 0 0 0